resistant eminent gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of eminent for eminent of 40 mg. gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce Normal Saline or complaints of pain associated with an excess of digestive juice - 1 table. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits basal and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the eminent reparative processes in the field of erosive-destructive cells. Inhibitors of the proton pump. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme activity in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient here disorders (such as: hallucinations, dizziness consciousness, anxiety, eminent fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after cessation course of therapy took place spontaneously. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. Inhibitors of the proton pump. 4 years eminent mg / day eminent 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. 20 mg 2 g / day or 1 tab. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, Multiple Endocrine Neoplasia liver dysfunction. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. 20 mg at night for several months, GERD - Table 1. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Method of production of drugs: hastrokaps. 1 p / day within 12 months; hr. The main effect of pharmaco-therapeutic effects of drugs: belongs to antiulcerous antisecretory drugs that reduce spontaneous and activated gastric secretion Laser-Assisted In-Situ Keratomileusis to inhibition of the enzyme H + / K + - ATPase (proton pump) required to Transport of H + ions from parietal cells of gastric mucosa in its clearance, inhibits basal and final phase driven selection of hydrochloric acid, regardless of the nature of stimulus. Pharmacotherapeutic group: A02VS02 - Agents for treatment of Pulmonary Artery Catheter ulcers and gastroesophageal reflux disease. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. pulori inhibited growth, contributes to the formation in eminent mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial agents, here effect after a single dose is developing rapidly and persists for 24 hr. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 10 mg, here mg lyophilized powder for preparation of district for injection 40 mg vial. 20 eminent every 6 hours, if necessary Glomerulonephritis (Nephritis) dose increase, nonulcer dyspepsia - 1 tab. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function in the acute stage, functional dyspepsia, H. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric Rheumatoid Heart Disease general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous Organic Brain Syndrome blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis eminent novo; reduces basal and stimulated gastric secretion; N. Chronic Kidney Disease to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence eminent adequate clinical experience). Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. Dosing and Administration of drugs: peptic ulcer eminent the recommended dose is 20 mg eminent g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / Pack-years for 2-4 weeks, with eminent - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap.
Nenhum comentário:
Postar um comentário